1984
DOI: 10.1016/0378-5173(84)90159-5
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring radiolabelled antacid preparations in the stomach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
15
0
1

Year Published

1984
1984
2013
2013

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 4 publications
0
15
0
1
Order By: Relevance
“…Jenkins et al studied emptying four hours after the meal27 and May et al 30 minutes after a liquid caloric meal. 28 In this study at all time intervals the emptying of magaldrate was significantly slower than that of Maalox. This might have been due to the special chemical structure of magaldrate, to its ability to adhere to the stomach wall, or to its different capacity for binding proteins.…”
Section: Discussionmentioning
confidence: 44%
See 1 more Smart Citation
“…Jenkins et al studied emptying four hours after the meal27 and May et al 30 minutes after a liquid caloric meal. 28 In this study at all time intervals the emptying of magaldrate was significantly slower than that of Maalox. This might have been due to the special chemical structure of magaldrate, to its ability to adhere to the stomach wall, or to its different capacity for binding proteins.…”
Section: Discussionmentioning
confidence: 44%
“…But Maalox, with a t1/2 of 52 3 (5 2) minutes, shows a rate ofemptying similar to that found for a caloric liquid (Clinifeed ISO, Roussel Laboratories, Wembley Park, UK). 28 wllTc labelling of antacids containing AI(OH)3 and Mg(OH)2 is feasible, stability is satisfactory, and gastric emptying of labelled antacids can be monitored by scintigraphic techniques. Therefore, gastric emptying of labelled antacids may be useful in monitoring how long antacids remain in patients' stomachs.…”
Section: Discussionmentioning
confidence: 99%
“…Previous work in our laboratories has demonstrated that some alginate-bicarbonate anti-reflux formulations produce a floating layer in vivo (1). A recent study has demonstrated that a n alginate formulation containing antacid materials in addition to the bicarbonate required to elevate the 'raft' mixed and emptied with the food and did not show a prolonged gastric residence (2).…”
mentioning
confidence: 98%
“…5 Omeprazole is very effective in reducing gastric acidity, and is used for treating conditions such as reflux oesophagitis, peptic ulceration and Zollinger-Ellison syndrome. 3,7 A similar scintigraphic study using Liquid Gaviscon ® (10 ml) and tablet (one tablet) formulations showed raft formation in both fasting and fed volunteers for both product formulations. 8 Another scintigraphic study demonstrated that cimetidine pre-treatment did not affect the raft formation of Liquid Gaviscon ® .…”
Section: Introductionmentioning
confidence: 99%
“…3,4 Omeprazole, a substituted benzimidazole, is a potent long-acting inhibitor of gastric acid secretion that acts by inhibiting H + /K + adenosine triphosphatase, which is responsible for hydrogen ion secretion by the gastric parietal cell. 5 Omeprazole is very effective in reducing gastric acidity, and is used for treating conditions such as reflux oesophagitis, peptic ulceration and Zollinger-Ellison syndrome.…”
Section: Introductionmentioning
confidence: 99%